Display options
Share it on

Adv Biol Chem. 2016 Dec;6(6):193-215. doi: 10.4236/abc.2016.66017. Epub 2016 Dec 30.

Evaluation of Silicon Phthalocyanine 4 Photodynamic Therapy Against Human Cervical Cancer Cells In Vitro and in Mice.

Advances in biological chemistry

Jill A Gadzinski, Jianxia Guo, Brian J Philips, Per Basse, Ethan K Craig, Lisa Bailey, John T Comerci, Julie L Eiseman

Affiliations

  1. Magee Women's Hospital of the University of Pittsburgh, Department of Obstetrics/Gynecology/Reproductive Sciences, 300 Halket Street, Pittsburgh, USA, 15213.
  2. Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, and Department of Pharmacology and Chemical Biology, School of Medicine, University of Pittsburgh, 5117 Centre Ave., Pittsburgh, PA 15213.
  3. Cancer Immunology Program, University of Pittsburgh Cancer Institute, and Department of Immunology, School of Medicine, University of Pittsburgh, 5117 Centre Ave. Pittsburgh, PA 15213.
  4. School of Medicine, Unversity of Pittsburgh, 5117 Centre Ave, Pittsburgh, PA 15232.

PMID: 28890844 PMCID: PMC5589197 DOI: 10.4236/abc.2016.66017

Abstract

BACKGROUND: Cervical cancer is the second most common cancer in women worldwide [1]. Photodynamic therapy has been used for cervical intraepithelial neoplasia with good responses, but few studies have used newer phototherapeutics. We evaluated the effectiveness of photodynamic therapy using Pc 4 in vitro and in vivo against human cervical cancer cells.

METHODS: CaSki and ME-180 cancer cells were grown as monolayers and spheroids. Cell growth and cytotoxicity were measured using a methylthiazol tetrazolium assay. Pc 4 cellular uptake and intracellular distrubtion were determined. For in vitro Pc 4 photodynamic therapy cells were irradiated at 667nm at a fluence of 2.5 J/cm

RESULTS: The IC

CONCLUSIONS: Pc 4 photodynamic therapy caused death within cervical cancer cells and xenografts, supporting development of Pc 4 photodynamic therapy for treatment of cervical cancer. Support: P30-CA47904, CTSI BaCCoR Pilot Program.

Keywords: Silicon Phthalocyanine 4; cervical cancer; lasers; photodynamic therapy

References

  1. Cancer Chemother Pharmacol. 1999;44(4):283-94 - PubMed
  2. Eur J Surg Oncol. 2013 Dec;39(12):1428-34 - PubMed
  3. Cancer Biol Med. 2012 Mar;9(1):9-17 - PubMed
  4. J Biotechnol. 2010 Jul 1;148(1):3-15 - PubMed
  5. J Natl Cancer Inst. 2009 May 20;101(10):696-7 - PubMed
  6. ACS Chem Biol. 2015 May 15;10(5):1239-46 - PubMed
  7. Photochem Photobiol. 2009 Jul-Aug;85(4):1011-9 - PubMed
  8. Lasers Surg Med. 2006 Jun;38(5):439-44 - PubMed
  9. N Engl J Med. 2003 Feb 6;348(6):518-27 - PubMed
  10. Lasers Surg Med. 2013 Nov;45(9):564-72 - PubMed
  11. Cancer Res Treat. 2004 Dec;36(6):389-94 - PubMed
  12. Lasers Surg Med. 2010 Dec;42(10):728-35 - PubMed
  13. Mol Pharm. 2013 May 6;10(5):1988-97 - PubMed
  14. Cancer. 1978 Aug;42(2):570-80 - PubMed
  15. EJNMMI Res. 2013 Aug 02;3(1):60 - PubMed
  16. World J Clin Oncol. 2014 May 10;5(2):86-92 - PubMed
  17. PLoS One. 2012;7(6):e38583 - PubMed
  18. Technol Cancer Res Treat. 2005 Jun;4(3):283-93 - PubMed
  19. Cancers (Basel). 2011;3(2):2516-39 - PubMed
  20. Eur J Gynaecol Oncol. 2006;27(3):239-42 - PubMed
  21. Acta Pathol Jpn. 1988 Nov;38(11):1445-52 - PubMed
  22. Photochem Photobiol Sci. 2002 Jan;1(1):1-21 - PubMed
  23. Clin Exp Dermatol. 2011 Aug;36(6):645-51 - PubMed

Publication Types

Grant support